Jassey, DOSinus infection symptoms and cold symptoms often appear similar, but there are some key differences that impact ...

Other treatments for CU include leukotriene inhibitors (Singulair), immunosuppressives (cyclosporine, dapsone), Danazol, beta-blockers (propranolol), topical scopolamine, and omalizumab (Xolair).

Companies are exploring alternative treatment pathways and have several novel classes of drugs for COPD in development (Table 1), including inhibitors of leukotriene B 4 receptors and chemokine ...

Ginger is a well-known anti-inflammatory. It may reduce the production of inflammatory molecules like prostaglandin and leukotriene as well as pro-inflammatory cytokines. These are a type of ...

Consider this: a research scientist submits a manuscript to a journal. The topic and advance seem to be a perfect fit for the journal's scope. But the manuscript is summarily rejected without ...

Kathryn L. Grant, Pharm.D., Assistant Professor College of Pharmacy, Craig D. Schneider, M.D., Fellow, Program in Integrative Medicine College of Medicine, University ...

Asthma is a significant global health concern, impacting over 339 million people worldwide – writes Theresa Lowry-Lehnen ...

It is clear from the available literature that much of the evidence supporting treatment recommendations for uremic bleeding comes from studies performed 25–30 years ago. At that time, medical ...

Akari’s lead asset, investigational nomacopan, is a bispecific recombinant inhibitor of complement C5 activation and leukotriene B4 (LTB4) activity. The company is conducting pre-clinical research of ...

Akari Therapeutics, Plc (Nasdaq: AKTX), an innovative biotechnology company developing advanced therapies for autoimmune and inflammatory diseases ...